V E Steele
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
-
- Estrogen and related hormone effects
Papers in
-
- Glutathione Transferases and Polymorphisms 1
- Angiogenesis and VEGF in Cancer 1
-
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Gary J. Kelloff (3 shared papers)Clinton J. Grubbs (2 shared papers)Donald L. Hill (1 shared paper)Jaime L. Masferrer (1 shared paper)Alane Koki (1 shared paper)Karen Seibert (1 shared paper)Ronald A. Lubet (1 shared paper)K. Leahy (1 shared paper)
- Journals
- In Vitro Cellular & Developmental Biology - Animal (1 paper)PubMed (5 papers)
- Partner nations
- United States
In The Last Decade
V E Steele
6 papers receiving 380 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 159
- Genetics 165
- Biochemistry 40
- Cancer Research 73
- Pharmacology 30
Countries citing papers authored by V E Steele
This map shows the geographic impact of V E Steele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V E Steele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V E Steele more than expected).
Fields of papers citing papers by V E Steele
This network shows the impact of papers produced by V E Steele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V E Steele. The network helps show where V E Steele may publish in the future.
Co-authors
The 23 scholars most cited alongside V E Steele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. | 2000 | 219 |
| 2 | Aromatase inhibitors as potential cancer chemopreventives. | 1998 | 58 |
| 3 | Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. | 1994 | 49 |
| 4 | Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. | 1998 | 37 |
| 5 | A quantitative angiogenesis model for efficacy testing of chemopreventive agents. | 2002 | 28 |
| 6 | Response of rosiglitazone, UAB 30, and atorvastatin in the human melanoma prevention assayl. | 2006 | 1 |
About V E Steele
V E Steele is a scholar working on Molecular Biology, Pharmacology, Genetics, Cancer Research and Computational Theory and Mathematics, having authored 6 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (2 papers), Estrogen and related hormone effects (2 papers), Inflammatory mediators and NSAID effects (2 papers), Computational Drug Discovery Methods (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Glutathione Transferases and Polymorphisms (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Pharmacology (159 citations), Genetics (165 citations), Biochemistry (40 citations), Cancer Research (73 citations) and Pharmacology (30 citations). V E Steele has collaborated with scholars based in United States. Frequent co-authors include Gary J. Kelloff, Clinton J. Grubbs, Donald L. Hill, Jaime L. Masferrer, Alane Koki, Karen Seibert, Ronald A. Lubet, K. Leahy, R Lubet and James A. Crowell. Their work appears in journals such as In Vitro Cellular & Developmental Biology - Animal and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.